Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Xospata for relapsed or refractory FLT3 mutation-positive AML

Oct. 25, 2019

FDA approves Baxdela for community-acquired bacterial pneumonia

Oct. 25, 2019

NIAID awards contract to UAB to study Bexsero for gonorrhea prevention

Oct. 25, 2019

New phase I trial investigates MB-108 in recurrent glioblastoma multiforme

Oct. 25, 2019

Syros reports new data from phase II trial of SY-1425 in newly diagnosed unfit AML

Oct. 25, 2019

Japan Tobacco describes new SLC5A1 inhibitors

Oct. 25, 2019

Merck KGaA synthesizes new IRAK inhibitors

Oct. 25, 2019

AbbVie and Galapagos identify mutant CFTR correctors for cystic fibrosis

Oct. 25, 2019

Janssen Pharmaceutica presents new ionotropic glutamate GluN2B receptor antagonists

Oct. 25, 2019

Aurigene Discovery Technologies divulges CDK12 and CDK13 inhibitors

Oct. 25, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...